Short answer
Larimar Therapeutics, Inc. (LRMR) filed an 8-K current report with the SEC on May 19, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Three Class III directors elected through 2029, preserving board continuity.
Larimar Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Three Class III directors elected through 2029, preserving board continuity
- Executive compensation approved; annual say-on-pay votes selected through the next frequency vote
- Shareholders approved increasing authorized common shares from 115,000,000 to 215,000,000, enabling future capital raising or equity issuance
- PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2026
- Proposals 2, 4, and 5 received strong support, with 73,822,237, 90,784,651, and 89,732,486 votes for respectively
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Larimar Therapeutics, Inc. 8-K filings
Get the next LRMR 8-K as it lands
Follow LRMR for push alerts, or ask the research agent what this filing means.